Drug entrapment in surfactant vesicles.

Surfactant vesicles, formed from dioctadecyldimethylammonium chloride, entrapped 8-azaguanine, methotrexate and 6-mercaptopurine in amounts greater than liposomes. Changes in pH and addition of cholesterol influence drug entrapment and release.     

Facilitated transport of 6-mercaptopurine and 6-thioguanine and non-mediated permeation of 8-azaguanine in novikoff rat hepatoma cells and relationship to intracellular phosphoribosylation

6-Mercaptopurine and 6-thioguanine strongly inhibited the zero-trans entry of hypoxanthine into Novikoff rat hepatoma cells which lacked hypoxanthine/guanine phosphoribosyltransferase, whereas 8-azaguanine had no significant effect. 6-Mercaptopurine was transported by the hypoxanthine carrier with about the same efficiency as its natural substrates (Michaelis-Menten constant = 372 ± 23 μM; maximum velocity = 30 ± 0.7 pmol/μl cell H₂O per s). 8-Azaguanine entry into the cells, on the other hand, showed no sign of saturability and was not significantly affected by substrates of the hypoxanthine/guanine carrier. The rate of entry of 8-azaguanine at 10–100 μM amounted to only about 5% of that of hypoxanthine transport and was related to its lipid solubility in the same manner as observed for various substances whose permeation through the plasma membrane is believed to be non-mediated. Only the non-ionized form of 8-azaguanine (pK_a = 6.6) permeated the cell membrane.Studies with wild type Novikoff cells showed that permeation into the cell was the main rate-determining step in the conversion of extracellular 8-azaguanine to intracellular aza-GTP and its incorporation into nucleic acids. In contrast, 6-mercaptopurine was rapidly transported into cells and phosphoribosylated; the main rate-determining step in its incorporation into nucleic acids was the further conversion of 6-mercaptopurine riboside 5'-monophosphate.     

Quantitation of 6-mercaptopurine in biologic fluids using high-performance liquid chromatography: A selective and novel procedure

A simple, selective, sensitive and rapid procedure is described for the quantitation of 6-mercaptopurine (6-MP) in biological fluids. A sensitivity of at least 5 ng/ml is easily achieved in plasma on a reversed-phase octadecylsilane (C₁) column using a high-performance liquid chromatography system following an initial protein precipitation and a clean-up step. Mean extractability of the drug from plasma following this procedure is greater than 98% and the overall coefficient of variation for the assay is below 6%. Plasma levels of 6-MP were measured in a rhesus monkey for 12 h following an intravenous administration of a single bolus dose (4 mg/kg) of 6-MP.     

Isolation and characterization of mutants of mesophilic methanogenic bacteria resistant to analogues of DNA bases and nucleosides

Spontaneous mutants of mesophilic Methanobacterium, Methanobrevibacter and Methanosarcina species resistant to 6-mercaptopurine, 5-fluorouracil, 8-azaguanine, 6-azauracil or 5-fluorodeoxyuridine were isolated. Low level resistant mutants were unstable but highly resistant strains (resistance factor greater than 10-fold) were stable and showed growth characteristics comparable to the parent. Wild type strains showed linear uptake of hypoxanthine and uracil into cells, but guanine uptake was only detected in Methanosarcina mazei. 6-Mercaptopurine-resistant clones of Methanobacterium and Methanobrevibacter species and 8-azaguanine-resistant clones of Methanosarcina mazei showed reduced uptake of hypoxanthine and guanine respectively, but no evidence for altered permeability of 5-fluoro-and 6-azauracil-resistant strains to uracil was obtained. Double resistant mutants of Methanobacterium sp. strain FR-2 were characterised. Although these generally exhibited reduced specific growth rates, several were selected which showed similar growth to the parent.Abbreviations DSM Deutsche Sammlung von Mikroorganismen, Federal Republic of Germany - MJC minimum inhibitory concentration - cfu colony forming unit - MP 6-mercaptopurine - FU 5-fluorouracil - FDU 5-fluorodeoxyuridine - AG 8-azaguanine - AU 6-azauracil - DA l-deazaadenosine     

Nature and position of functional group on thiopurine substrates influence activity of xanthine oxidase — Enzymatic reaction pathways of 6-mercaptopurine and 2-mercaptopurine are different

Xanthine oxidase-catalyzed hydroxylation reactions of the anticancer drug 6-mercaptopurine (6-MP) and its analog 2-mercaptopurine (2-MP) as well as 6-thioxanthine (6-TX) and 2-thioxanthine (2-TX) have been studied using UV-spectroscopy, high pressure liquid chromatography, photodiode array, and liquid chromatography-based mass spectral analysis. It is shown that 6-MP and 2-MP are oxidatively hydroxylated through different pathways. Enzymatic hydroxylation of 6-MP forms 6-thiouric acid in two steps involving 6-TX as the intermediate, whereas 2-MP is converted to 8-hydroxy-2-mercaptopurine as the expected end product in one step. Surprisingly, in contrast to the other thiopurines, enzymatic hydroxylation of 2-MP showed a unique hyperchromic effect at 264 nm as the reaction proceeded. However, when 2-TX is used as the substrate, it is hydroxylated to 2-thiouric acid. The enzymatic hydroxylation of 2-MP is considerably faster than that of 6-MP, while 6-TX and 2-TX show similar rates under identical reaction conditions. The reason why 2-MP is a better substrate than 6-MP and how the chemical nature and position of the functional groups present on the thiopurine substrates influence xanthine oxidase activity are discussed.     

PROMOTION OF PERITHECIAL INITIALS IN MONACROSPORIUM DOEDYCOIDES BY 6–METHYL PURINE

The promotion of perithecial initials in the imperfect fungus Monacrosporium doedycoides is enhanced by the addition of the RNA synthesis inhibitor 6-methyl purine (6-MP). The addition of two other RNA inhibitors (8-azaguanine and actinomycin-D) causes the promotion of initials but not at the magnitude observed with 6-MP. Application of a protein synthesis inhibitor (cycloheximide), a base analog (5-fluorouracil), or an amino acid analog (p-fluorophenyl-alanine) are not promotive on initial formation and can be inhibitory. The apparent cause for the promotion of perithecial initials in the imperfect fungus is that sexual structures are inhibited by mRNA's synthesized by the organism and the addition of 6-MP prohibits their synthesis.     

A complex genetic locus controlling purine nucleotide biosynthesis in yeast

Summary Mutants of the genes pur1 to pur6 excrete purine when in combination with the allele su-pur ⁺ and are resistant to growth inhibition by 8-azaadenine (8-AzAd) and 8-azaguanine (8-AzGu). In combination with su-pur, which suppresses purine excretion, pur1 and pur2 are analogue sensitive; pur3 is slightly resistant to 8-AzAd; pur4 is slightly resistant to both analogues and pur5 is completely resistant to 8-AzGu. Crosses of the pur mutants to dap, which causes sensitivity to 2,6-diaminopurine (2,6-DAP), guanine and 6-mercaptopurine (6-MP), show that dap also suppresses purine excretion and is closely linked to pur6. In combination with dap, pur1 and pur3 are analogue sensitive; pur4 is hypersensitive to guanine but resistant to 6-MP; pur5 is resistant to 2,6-DAP and guanine whilst pur2 is hypersensitive to all three compounds.The gene slw, which, like pur2, potentiates the effects of dap, also suppresses purine excretion but is not linked to any of the pur genes. The diploid slw/pur3 excretes purine.Tests for functional allelism were carried out on the closely linked genotypes su-pur ⁺, su-pur, dap, pur6, PUR6 and ade4. The results of these tests indicate that all six genotypes are functionally allelic. It is suggested that a molecular complex of the products of pur1, pur3, pur4, pur6 and slw is involved in the control of purine nucleotide biosynthesis in yeast.     

Metabolic properties of an azaguanine-resistant variant of Chinese hamster ovary cells (azarts) with normal levels of hypoxanthine-guanine phosphoribosyltransferase activity

Azarts Chinese hamster ovary cells were 20 to 50 times more resistant to 8-azaguanine and 50 to 10 times more resistant to both 6-thioguanine and 6-mercaptopurine than wild-type cells. Resistance correlated with a failure of azarts cells to incorporate 8-azaguanine into the nucleotide pool and into nucleic acids. The uptake of hypoxanthine and guanine, on the other hand, was about the same in both types of cells and the hypoxanthine-guanine phosphoribosyltransferase of the azarts cells as measured in cell lysates was unaltered both in concentration and kinetic properties with hypoxanthine as well as 8-azaguanine as substrate. Plasma membrane permeability to 8-azaguanine and the regulation of intracellular pH were also not altered in azarts cells and there was no significant degradation of 8-azaguanine or azaguanine nucleotides. We conclude therefore that in azarts cells the phosphoribosylation of 8-azaguanine per se is specifically blocked but that this effect is abolished upon cell lysis.     

Encapsulation of 8-azaguanine in single multiple compartment liposomes

Incorporation of [2-¹⁴C]-8-azaguanine into positively charged single and multiple component dipalmitoyl-DL-α-phosphatidylcholine and egg yolk phosphatidylcholine liposomes has been established. The extent of encapsulation in single compartment liposomes is 0.70–1.80% and it depends on the concentration of the added 8-azaguanine and the sonication time. Utilizing dialysis, the leakage of the drug from the single compartment liposomes after 20 hours was determined to be 4–34%. At high concentration of the added drug it is possible to encapsulate 18×10^?9 pmole of 8-azaguanine per liposome. Percentages of uptake into multicompartment liposomes are 3.6–5.4%. A preliminary study has been carried out on the effects of free and single and multiple compartment encapsulated 8-azaguanine on the survival and weight gains of leukemia L-1210 bearing mice.     

Improved entrapment of drugs in modified liposomes

Incorporation of 8-azaguanine and 6-mercaptopurine into single compartment dipalmitoyl-DL-α-phosphatidylcholine liposomes has been increased dramatically by the presence of chloranil transfer complex formation. The enhanced entrapment is due to charge. The charge transfer complex readily decomposes to the parent donor drug and chloranil acceptor. Chloranil, however, may be toxic. Using 3,5-dinitrobenzoyl-n-butylamide and 3,5-dinitrobenzoyl phosphatidylethanolamine as electron donors did not result in enhanced entrapments.     

Incorporation of Exogenous Purines and Pyrimidines by Methanococcus voltae and Isolation of Analog-Resistant Mutants

Methanococcus voltae incorporated exogenous adenine, guanine, hypoxanthine, and uracil, but not thymine. Growth of M. voltae was also sensitive to purine and pyrimidine analogs. Of the 20 analogs tested, 12 were inhibitory at 1 mg/ml. The most effective inhibitors were purine analogs with endocyclic substitutions. Nucleoside analogs and analogs with exocyclic substitutions or additions were less effective. Four purine analogs, 8-aza-2,6-diaminopurine, 8-azaguanine, 8-azahypoxanthine, and 6-mercaptopurine and one pyrimidine analog, 6-azauracil, were especially toxic. The MICs were 20, 0.5, 2.0, 80, and 10 μg/ml, respectively. Spontaneous resistance mutants were isolated for these five analogs. The MICs for these mutants were 20.5, 8.2, >65, >41, and 20.5 mg/ml, respectively. These concentrations far exceeded the solubilities of the analogs and represented an increase in resistance of at least three orders of magnitude. In addition to demonstrating cross resistance to several of the analogs, four of these mutants lost the ability to incorporate exogenous bases. These appeared to be mutations in the salvage pathways for purines and pyrimidines. In contrast, the mutant resistant to 6-mercaptopurine was not defective in purine uptake. Instead, it degraded 6-mercaptopurine. In the presence or absence of high concentrations of the analogs, the growth rates of the resistant mutants were no less than one-half of the growth rate of the wild type in the absence of the analog. The high level of resistance and rapid growth are very desirable properties for the application of the mutants in genetic experiments.     

Synthesis of closo-Dodecaboryl Lipids and their Liposomal Formation for Boron Neutron Capture Therapy

High accumulation and selective delivery of boron into tumor tissues are the most important requirements to achieve efficient neutron capture therapy of cancers. We focused on liposomal boron delivery system to achieve a large amount of boron delivery to tumor. We succeeded in the synthesis of the double-tailed boron cluster lipids 4a–c and 5a–c, which has a B₁₂H₁₁S-moiety as a hydrophilic function, by S-alkylation of B₁₂H₁₁SH with bromoacetyl and chloroacetocarbamate derivatives of diacylglycerols. Size distribution of liposomes prepared from the boron cluster lipid 4b, dimyristoylphosphatidylcholine, polyethyleneglycol-conjugated distearoylphosphatidylethanolamine, and cholesterol was determined as 100 nm in diameter by an electrophoretic light scattering spectrophotometer. Calcein-encapsulation experiments revealed that these boronated liposomes are stable at 37 °C in fetal bovine serum solution for 24 h.     

6-Mercaptopurine and Daunorubicin Double Drug Liposomes—Preparation,Drug-Drug Interaction and Characterization

This article addresses and investigates the dual incorporation of daunorubicin (DR) and 6-mercaptopurine (6-MP) in liposomes for better chemotherapy. These drugs are potential candidates for interaction due to the quinone (H acceptor) and hydroxyl (H donor) groups on DR and 6-MP, respectively. Interactions between the two drugs in solution were monitored by UV/Vis and fluorescence spectroscopy. Interaction between the two drugs inside the liposomes was evaluated by HPLC (for 6-MP) and by fluorescence spectroscopy (for daunorubicin) after phospholipase-mediated liposome lysis. Our results provide evidence for the lack of interaction between the two drugs in solution and in liposomes. The entrapment efficiencies of 6-MP in the neutral Phosphatidyl choline (PC):Cholesterol (Chol):: 2:1 and anionic PC:Chol:Cardiolipin (CL) :: 4:5:1 single and double drug liposomes were found to be 0.4% and 1.5% (on average), respectively. The entrapment efficiencies of DR in the neutral and anionic double drug liposomes were found to be 55% and 31%, respectively. The corresponding entrapment of daunorubicin in the single drug liposomes was found to be 62% on average. Our thin layer chromatography (TLC) and transmission electron microscopy (TEM) results suggest stability of lipid and liposomes, thus pointing plausible existence of double drug liposomes. Cytotoxicity experiments were performed by using both single drug and double drug liposomes. By comparing the results of phase contrast and fluorescence microscopy, it was observed that the double drug liposomes were internalized in the jurkat and Hut78 (highly resistant cell line) leukemia cells as viewed by the fluorescence of daunorubicin. The cytotoxicity was dose dependent and had shown a synergistic effect when double drug liposome was used.     

Vitamin B<Subscript>12</Subscript> as a carrier for targeted platinum delivery: in vitro cytotoxicity and mechanistic studies

It is attractive to use vitamin B₁₂ as a carrier for targeted delivery of cytotoxic agents such as platinum complexes owing to the high demand for vitamin B₁₂ by fast proliferating cells. The basic {B₁₂–CN–Pt^II} conjugates are recognized by intracellular enzymes and converted to coenzyme B₁₂ in an enzymatic adenosylation assay. The reductive adenosylation of {B₁₂–CN–Pt^II} conjugates leads to the release of the Pt^II complexes; thus, {B₁₂–CN–Pt^II} conjugates can be considered as prodrugs. It is important not only to elucidate the activity of the cisplatin–B₁₂ conjugates, but also to understand the mode of action on a molecular level. Chemical reduction of {B₁₂–CN–Pt^II} conjugates with cobaltocene yielded cob(II)alamin and induced release of the corresponding Pt^II species. Kurnakov tests and coordination of 2′-deoxyguanosine or GMP to the released Pt^II complexes allowed isolation and characterization of Pt^II complexes as released during enzymatic adenosylation. The biological activity of these Pt^II complexes was evaluated. Since the cleaved Pt^II complexes show cytotoxicity, the {B₁₂–CN–Pt^II} conjugates can be used for specific targeting of cancer cells and therapeutic drug delivery. Preliminary in vitro cytotoxicity studies indicated lower activity (IC₅₀ between 8 and 88 μM) than found for pure cisplatin. Since active transport and receptor-mediated uptake limits the intracellular {B₁₂–CN–Pt^II} concentration, comparison with pure cisplatin is of limited use. We could show that the Pt^II complexes cleaved from B₁₂ exerted a cytotoxicity comparable to that of cisplatin itself. Cytotoxicity studies in vitamin B₁₂ free media showed a dependence on the addition of transcobalamin II for B₁₂–Pt(II) conjugates.     

Syntheses, electrolytic behaviour and antifungal activities of Zn(II) complexes of isomers of 3,10-C-meso-3,5,7,7,10,12,14,14-octamethyl-1,4,8,11-tetraazacyclotetradecane (L). Crystal and molecular structure of [ZnLB(NO3)]NO3 (LB = a,e,a,e-L)

The isomeric cyclam ligands Me₈[14]anes, designated by L_A, L_B and L_C, produce, on reaction with zinc(II)nitrate, zinc(II)sulphate or zinc(II)chloride corresponding complexes, i.e. dinitrato/mononitrato-nitrate complexes [ZnL(NO₃)₂]/[ZnL(NO₃)](NO₃) (L = L_A, L_B or L_C, where the indices A, B and C refer to differing orientations of the four methyl groups on secondary carbons of Me₈[14]ane)_, the diaqua-sulphates [ZnL(H₂O)₂]SO₄ (L = L_A, L_B or L_C), and the diaqua dichloride and dichlorido complexes [ZnL(H₂O)₂]Cl₂ (L = L_A or L_C) or [ZnL_BCl₂], respectively. The complexes have been characterised on the basis of elemental analyses, IR, UV-Vis, ¹H and ¹³C NMR spectroscopies, magnetic and conductance data. The structure of [ZnL_B(NO₃)](NO₃) has been determined by X-ray crystallography. The zinc centre is coordinated to a N₄O donor set in a square-pyramidal geometry. The complexes show differing electrolytic behaviour in different solvents. In chloroform, the complexes are non-electrolytes, indicating that both anions are coordinated to Zn²⁺. Antifungal activity of the ligands and complexes against the phytopathogenic fungi Alternaria alternata and Colletotrichum corcolei have been investigated, and positive results were noted.     

Synthesis, spectroscopic and electrochemical characterization of water soluble [(η-C5H5)2Mo(thionucleobase/thionucleoside)]Cl2 complexes

A series of water soluble molybdenocene complexes of general formula [(η⁵-C₅H₅)₂Mo(L)]Cl₂ (L=6-mercaptopurine (2), 6-mercaptopurine ribose (3), 2-amino-6-mercaptopurine (4), 2-amino-6-mercaptopurine ribose (5)) have been prepared by reacting Cp₂MoCl₂ (1) with the corresponding thionucleobase/thionucleoside in a (2:1) THF/MeOH solvent mixture. The complexes have been characterized by spectroscopic methods (NMR, UV-Vis, IR and MS). ¹H NMR spectroscopic data (DMSO-d₆) on the complexes suggest a S-Mo-N(7) coordination by the thionucleobase/thionucleoside. In buffer solution NMR data suggest that the thionucleobase/thionucleoside remains coordinated to molybdenum probably through S(6) and assisted by either N(7) or N(1) atoms. Intermediate species such as [Cp₂Mo(η¹-L)(H₂O)]^2+/1+ where the L is acting as monodentate ligand are possible in solution. Electrochemical characterization has also been pursued by cyclic voltammetry in DMSO and buffer solution. In DMSO, the complexes including the molybdenocene dichloride exhibit reversible redox behavior. On the other hand, in buffer solution, the oxidation process is irreversible for all the species.     

6-mercaptopurine and daunorubicin double drug liposomes-preparation, drug-drug interaction and characterization

This article addresses and investigates the dual incorporation of daunorubicin (DR) and 6-mercaptopurine (6-MP) in liposomes for better chemotherapy. These drugs are potential candidates for interaction due to the quinone (H acceptor) and hydroxyl (H donor) groups on DR and 6-MP, respectively. Interactions between the two drugs in solution were monitored by UV/Vis and fluorescence spectroscopy. Interaction between the two drugs inside the liposomes was evaluated by HPLC (for 6-MP) and by fluorescence spectroscopy (for daunorubicin) after phospholipase-mediated liposome lysis. Our results provide evidence for the lack of interaction between the two drugs in solution and in liposomes. The entrapment efficiencies of 6-MP in the neutral Phosphatidyl choline (PC):Cholesterol (Chol):: 2:1 and anionic PC:Chol:Cardiolipin (CL) :: 4:5:1 single and double drug liposomes were found to be 0.4% and 1.5% (on average), respectively. The entrapment efficiencies of DR in the neutral and anionic double drug liposomes were found to be 55% and 31%, respectively. The corresponding entrapment of daunorubicin in the single drug liposomes was found to be 62% on average. Our thin layer chromatography (TLC) and transmission electron microscopy (TEM) results suggest stability of lipid and liposomes, thus pointing plausible existence of double drug liposomes. Cytotoxicity experiments were performed by using both single drug and double drug liposomes. By comparing the results of phase contrast and fluorescence microscopy, it was observed that the double drug liposomes were internalized in the jurkat and Hut78 (highly resistant cell line) leukemia cells as viewed by the fluorescence of daunorubicin. The cytotoxicity was dose dependent and had shown a synergistic effect when double drug liposome was used.     

Attempt to enhance resistance to infection in 6-mercaptopurine treated mice by lysozyme administration and immunization withEscherichia coli O86 antigen

Long-term immunosuppressive therapy of mice with 6-mercaptopurine (6-MP) for 2 and/or 3 weeks results in partial lethality, decrease of total leukocyte count, of serum lysozyme level and in bacteremia. The adverse effect of 6-MP treatment could not be prevented by lysozyme administration; immunization withEscherichia coli O86 antigen further increased the lethality of 6-MP in mice. The results itress the potential danger of immunization with bacterial antigens during immunosuppressive therapy.     

Vitamins as effectors of monensin production byStreptomyces cinnamonensis

Vitamins added to submergedStreptomyces cinnamonensis cultures stimulated the production of monensins. Vitamins B₂, B₃, B₅ and B₁₂ enhanced the production by about 50%, vitamins B₁ and B₆ by 100%. The addition of biotin in optimal concentration resulted in more than 3-fold increase in total production.